Clinical trials
Hospitalization clinical trials
Below are recruiting hospitalization clinical trials, each written for real people, not researchers. We’re tracking 15,641 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07091305RecruitingPhase 2
Study of a new drug with chemotherapy for limited-stage small cell lung cancer
This trial tests an investigational drug called QL1706 combined with chemotherapy, given after standard chemoradiation, for people with limited-stage small cell lung cancer. The goal is to see if this combination helps keep the cancer from coming back.
ShanghaiAges 18–75 - NCT07091851Recruiting
Blood pressure support group for stroke survivors
This study tests whether a group-based program can help people with high blood pressure and a recent mild to moderate stroke better manage their blood pressure. You'll work with a team and use online tools to keep your blood pressure in a healthy range.
Boston, MassachusettsAges 35 years+ - NCT07091799Recruiting
Blood test to diagnose ALS using P2X4 markers
This study looks at a protein called P2X4 on immune cells in your blood to see if it can help diagnose ALS. You would give a blood sample to help researchers find a new way to identify ALS.
BordeauxAges 18 years+ - NCT07091942Recruiting
Curative therapy after Atezo-Bev for advanced liver cancer
This trial is for people with liver cancer who have already been treated with Atezo-Bev (a combination of atezolizumab and bevacizumab) and whose tumors have shrunk significantly. The goal is to see if further curative treatments can be used to improve outcomes.
Taipei, SelectAges Any age - NCT07092111Recruiting
Ear acupuncture to prevent nerve damage from chemotherapy in breast cancer
This trial tests if ear acupuncture can help prevent nerve damage caused by taxane chemotherapy in breast cancer patients. If you are starting 4 rounds of this chemo and have not had nerve issues before, this may be an option for you.
Nanjing, JiangsuAges 18–75 - NCT07092202RecruitingPhase 4
Firmonertinib and spinal injection for EGFR lung cancer with spread to brain lining
This trial tests combining a targeted pill (firmonertinib) with medication injected into the fluid around the spine for people with a specific type of lung cancer that has spread to the lining of the brain. It may offer a new option if you have already tried other EGFR drugs and are still having progression.
Wuhan, HubeiAges 18 years+ - NCT07092358Recruiting
Hereditary ataxia study in the Yangtze Delta region
This study looks at genetic ataxia (a condition that affects coordination) and uses advanced testing to learn more about it. It aims to help understand the disease better and find new ways to treat it.
Hangzhou, ZhejiangAges Any age - NCT07092423Recruiting
Special liquid tube feed for brain injury patients
This study tests a special liquid formula (semi-elemental nutrition) given through a feeding tube to people with severe traumatic brain injury. It aims to see if this formula is easier on the stomach and causes fewer digestive problems than standard tube feeds.
Xi'an, ShaanxiAges 18–75 - NCT07092696RecruitingPhase 2
Immunotherapy and chemoradiation for cervical cancer
This study tests whether combining immunotherapy with chemotherapy, followed by radiation plus immunotherapy, can work better than standard treatment for cervical cancer. It aims to help patients whose cancer has not spread yet.
TianjinAges 18–75 - NCT07092709RecruitingPhase 3
Tenecteplase for stroke patients who recently took blood thinners
This trial tests if the clot-busting drug tenecteplase is safe and effective for people having an ischemic stroke who have recently taken blood thinners (DOACs). If you qualify, you may receive either tenecteplase or a placebo within 24 hours of your last known well time.
Guangzhou, GuangdongAges 18 years+ - NCT07093203Recruiting
Rezafungin for fungal infection in the belly
This trial tests how well rezafungin, an antifungal medicine, spreads in belly fluid when given during surgery for a suspected fungal infection in the abdomen. It aims to see if it's a good treatment option for patients needing abdominal surgery.
Vandœuvre-lès-Nancy, LorraineAges 18 years+ - NCT07093294Recruiting
Predicting vedolizumab success with ultrasound in early Crohn's
This study uses intestinal ultrasound to see if vedolizumab can heal the gut in people recently diagnosed with Crohn's disease. It aims to find early signs that the treatment is working.
Changsha, HunanAges 18–80 - NCT07093437Recruiting
Comparing ways to secure urinary catheters in ICU patients
This study compares two methods of securing a urinary catheter to the thigh to see which works better. It's for patients in the intensive care unit (ICU) who need a catheter for more than 48 hours.
BarcelonaAges 18–99 - NCT07093450Recruiting
Reducing antibiotic use in intensive care safely
This trial tests a quality improvement program to help ICUs use fewer antibiotics without compromising patient safety. It looks at how well the intervention works to reduce antimicrobial use in critically ill patients.
Colatina, Espírito SantoAges 18 years+ - NCT07093502Recruiting
Predicting outcomes after weight-loss surgery for severe obesity
This study is creating a system to predict how well people do after weight-loss surgery for severe obesity. It focuses on patients getting either a sleeve gastrectomy or a gastric bypass and aims to improve recovery and long-term results.
Changsha, HunanAges 18–50 - NCT07094100Recruiting
Repairing knee cartilage with lab-grown tissue
This study tests whether lab-made cartilage can safely and effectively repair knee joint damage in adults. It may be an option if you have a cartilage defect from an injury or other cause and haven't had recent knee surgery.
Xinxiang, HenanAges 18–65 - NCT07094438RecruitingPhase 1
Brain stimulation and neck surgery for severe Alzheimer's
This early-stage trial tests combining deep brain stimulation (a device that sends electrical pulses to the brain) with a neck surgery that aims to improve brain fluid drainage. It's for people with severe Alzheimer's who can still walk and do not have other major health issues.
BeijingAges 40–80 - NCT07094529Recruiting
Tailored low blood sugar treatment for type 2 diabetes
This study tests a personalized approach to treating low blood sugar (hypoglycemia) in adults with type 2 diabetes. It aims to find out if this tailored treatment plan is practical and helpful for people who take certain diabetes medications (sulfonylureas or insulin).
Ottawa, OntarioAges 18 years+ - NCT07094724RecruitingPhase 2
Convalescent plasma for hospitalized West Nile virus patients
This trial tests whether giving high-dose antibody-rich plasma from recovered donors can help hospitalized adults fight West Nile fever more effectively. It is for patients who are older or have a weakened immune system.
Ramat GanAges 18 years+ - NCT07094763Recruiting
Tenecteplase for posterior stroke 4.5-24 hours after onset
This trial tests a clot-busting drug called tenecteplase for people who had a stroke affecting the back part of the brain (posterior circulation). It may be an option if you can get treatment between 4.5 and 24 hours after symptoms started.
HefeiAges 18–100 - NCT07095023Recruiting
Oral chemo and targeted therapy before breast cancer surgery
This trial tests a combination of an oral chemotherapy pill (paclitaxel) with two targeted antibodies (pertuzumab and trastuzumab) given before surgery for HER2-positive breast cancer. The goal is to shrink the tumor and make surgery more effective.
Beijing, Beijing MunicipalityAges 18–75 - NCT07095517RecruitingPhase 1
Preventing early-onset colorectal tumors with tirzepatide
This study tests if tirzepatide can help prevent early-onset colorectal tumors in people aged 18-50 who have had certain types of polyps removed. It aims to find risk factors and ways to stop colorectal cancer before it starts.
Boston, MassachusettsAges 18–50 - NCT07095829Recruiting
Predicting circulation after birth for severe pulmonary valve blockage
This study looks at babies with a severe heart defect where the pulmonary valve is blocked and the wall between the heart's lower chambers is intact. It aims to predict how well blood will flow after birth using ultrasound images taken during pregnancy.
MadridAges 4 months–6 months - NCT07095933RecruitingEarly Phase 1
Everolimus for hard-to-control focal epilepsy
This study tests whether the medicine everolimus (taken as a pill) can safely reduce seizures in adults with focal epilepsy that hasn't been controlled by other treatments. You would continue your current seizure medicines and add everolimus.
Beijing, Beijing MunicipalityAges 18–60
Hear when a new Hospitalization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hospitalization?
- Yes. Clin2 currently lists 15,641 recruiting hospitalization studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hospitalization trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hospitalization trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.